East Lansing's Iaso Therapeutics Raises $1.25M to Advance Vaccine Platform
Iaso Therapeutics recently closed the first portion of the company's $1.25 million Series Seed Preferred round of financing.
Source: dbusiness.com
Stay updated with breaking news from Robert Forgey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Iaso Therapeutics recently closed the first portion of the company's $1.25 million Series Seed Preferred round of financing.
Read about news from Carrum Health, New Enterprise Associates, American Medical Women's Association, and Iaso Therapeutics.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Iaso Therapeutics, a Michigan State University startup developing novel technologies for next-generation vaccines, recently closed the first...